Le Lézard
Classified in: Health
Subjects: MAV, WOM, PSF, CMG, CFG, DEI

Media Advisory - Prime Minister's itinerary for Friday, December 10, 2021


OTTAWA, ON, Dec. 9, 2021 /CNW/ -

Note: All times local

Ottawa, Ontario



Private meetings



9:30 a.m.

The Prime Minister will visit the Scarborough Health Network's Centenary Hospital, where he will meet with children and parents at a vaccination clinic. Parliamentary Secretary to the Minister of Justice and Attorney General of Canada Gary Anandasangaree, Member of Parliament for Scarborough Centre Salma Zahid, Member of Parliament for Scarborough?Guildwood John McKay, and Member of Parliament for Scarborough?Agincourt Jean Yip will be in attendance.




Note for media:


  • Pooled photo opportunity


12:00 p.m.

The Prime Minister, along with Deputy Prime Minister and Minister of Finance Chrystia Freeland, will meet with the Women's Economic Council, a Canadian organization advocating for women-centred community economic development.




Closed to media

This document is also available at https://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 22:00
Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its...

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 19:30
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...



News published on and distributed by: